FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2112097252> ?p ?o ?g. }

• W2112097252 endingPage "3296" @default.
• W2112097252 startingPage "3290" @default.
• W2112097252 abstract "The impact of stereotactic body radiotherapy (SBRT) on 3-year progression-free survival of medically inoperable patients with stage I non-small-cell lung cancer (NSCLC) was analyzed in a prospective phase II study.Fifty-seven patients with T1NOMO (70%) and T2N0M0 (30%) were included between August 2003 and September 2005 at seven different centers in Sweden, Norway, and Denmark and observed up to 36 months. SBRT was delivered with 15 Gy times three at the 67% isodose of the planning target volume.Progression-free survival at 3 years was 52%. Overall- and cancer-specific survival at 1, 2, and 3 years was 86%, 65%, 60%, and 93%, 88%, 88%, respectively. There was no statistically significant difference in survival between patients with T1 or T2 tumors. At a median follow-up of 35 months (range, 4 to 47 months), 27 patients (47%) were deceased, seven as a result of lung cancer and 20 as a result of concurrent disease. Kaplan-Meier estimated local control at 3 years was 92%. Local relapse was observed in four patients (7%). Regional relapse was observed in three patients (5%). Nine patients (16%) developed distant metastases. The estimated risk of all failure (local, regional, or distant metastases) was increased in patients with T2 (41%) compared with those with T1 (18%) tumors (P = .027).With a 3-year local tumor control rate higher than 90% with limited toxicity, SBRT emerges as state-of-the-art treatment for medically inoperable stage I NSCLC and may even challenge surgery in operable instances." @default.
• W2112097252 created "2016-06-24" @default.
• W2112097252 creator A5005280125 @default.
• W2112097252 creator A5009022418 @default.
• W2112097252 creator A5009104394 @default.
• W2112097252 creator A5016925675 @default.
• W2112097252 creator A5027486127 @default.
• W2112097252 creator A5028951234 @default.
• W2112097252 creator A5034925009 @default.
• W2112097252 creator A5034925806 @default.
• W2112097252 creator A5040363962 @default.
• W2112097252 creator A5043732356 @default.
• W2112097252 creator A5067254286 @default.
• W2112097252 creator A5072141016 @default.
• W2112097252 creator A5072863583 @default.
• W2112097252 creator A5076952530 @default.
• W2112097252 creator A5078869708 @default.
• W2112097252 creator A5080952754 @default.
• W2112097252 creator A5087206674 @default.
• W2112097252 creator A5091341224 @default.
• W2112097252 creator A5091641647 @default.
• W2112097252 date "2009-07-10" @default.
• W2112097252 modified "2023-10-16" @default.
• W2112097252 title "Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy" @default.
• W2112097252 cites W1867284234 @default.
• W2112097252 cites W1967821811 @default.
• W2112097252 cites W1972153012 @default.
• W2112097252 cites W1979497535 @default.
• W2112097252 cites W1980426429 @default.
• W2112097252 cites W1981410872 @default.
• W2112097252 cites W1992694261 @default.
• W2112097252 cites W2010264295 @default.
• W2112097252 cites W2010788180 @default.
• W2112097252 cites W2013982338 @default.
• W2112097252 cites W2024107960 @default.
• W2112097252 cites W2025251694 @default.
• W2112097252 cites W2041547867 @default.
• W2112097252 cites W2043339645 @default.
• W2112097252 cites W2043561789 @default.
• W2112097252 cites W2044564816 @default.
• W2112097252 cites W2052394223 @default.
• W2112097252 cites W2068175268 @default.
• W2112097252 cites W2077642996 @default.
• W2112097252 cites W2087065324 @default.
• W2112097252 cites W2094011295 @default.
• W2112097252 cites W2095695135 @default.
• W2112097252 cites W2100366409 @default.
• W2112097252 cites W2102184716 @default.
• W2112097252 cites W2104504726 @default.
• W2112097252 cites W2107814019 @default.
• W2112097252 cites W2111162768 @default.
• W2112097252 cites W2117494906 @default.
• W2112097252 cites W2120431409 @default.
• W2112097252 cites W2126414636 @default.
• W2112097252 cites W2139347600 @default.
• W2112097252 cites W2159746573 @default.
• W2112097252 doi "https://doi.org/10.1200/jco.2008.21.5681" @default.
• W2112097252 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19414667" @default.
• W2112097252 hasPublicationYear "2009" @default.
• W2112097252 type Work @default.
• W2112097252 sameAs 2112097252 @default.
• W2112097252 citedByCount "749" @default.
• W2112097252 countsByYear W21120972522012 @default.
• W2112097252 countsByYear W21120972522013 @default.
• W2112097252 countsByYear W21120972522014 @default.
• W2112097252 countsByYear W21120972522015 @default.
• W2112097252 countsByYear W21120972522016 @default.
• W2112097252 countsByYear W21120972522017 @default.
• W2112097252 countsByYear W21120972522018 @default.
• W2112097252 countsByYear W21120972522019 @default.
• W2112097252 countsByYear W21120972522020 @default.
• W2112097252 countsByYear W21120972522021 @default.
• W2112097252 countsByYear W21120972522022 @default.
• W2112097252 countsByYear W21120972522023 @default.
• W2112097252 crossrefType "journal-article" @default.
• W2112097252 hasAuthorship W2112097252A5005280125 @default.
• W2112097252 hasAuthorship W2112097252A5009022418 @default.
• W2112097252 hasAuthorship W2112097252A5009104394 @default.
• W2112097252 hasAuthorship W2112097252A5016925675 @default.
• W2112097252 hasAuthorship W2112097252A5027486127 @default.
• W2112097252 hasAuthorship W2112097252A5028951234 @default.
• W2112097252 hasAuthorship W2112097252A5034925009 @default.
• W2112097252 hasAuthorship W2112097252A5034925806 @default.
• W2112097252 hasAuthorship W2112097252A5040363962 @default.
• W2112097252 hasAuthorship W2112097252A5043732356 @default.
• W2112097252 hasAuthorship W2112097252A5067254286 @default.
• W2112097252 hasAuthorship W2112097252A5072141016 @default.
• W2112097252 hasAuthorship W2112097252A5072863583 @default.
• W2112097252 hasAuthorship W2112097252A5076952530 @default.
• W2112097252 hasAuthorship W2112097252A5078869708 @default.
• W2112097252 hasAuthorship W2112097252A5080952754 @default.
• W2112097252 hasAuthorship W2112097252A5087206674 @default.
• W2112097252 hasAuthorship W2112097252A5091341224 @default.
• W2112097252 hasAuthorship W2112097252A5091641647 @default.
• W2112097252 hasConcept C121608353 @default.
• W2112097252 hasConcept C126322002 @default.
• W2112097252 hasConcept C141071460 @default.
• W2112097252 hasConcept C143998085 @default.

• next